Lindsey Trickett
Investor Relations Contact presso F-STAR THERAPEUTICS, INC.
Profilo
Lindsey Trickett is currently the Vice President of Investor Relations at Prelude Therapeutics, Inc. and the VP of Investor Relations & Communications at F-star Therapeutics, Inc. She previously worked as the Vice President of Investor Relations at Intellia Therapeutics, Inc. Ms. Trickett received an undergraduate degree from the University of Kentucky and an MBA from Georgetown University.
Posizioni attive di Lindsey Trickett
| Società | Posizione | Inizio |
|---|---|---|
| F-STAR THERAPEUTICS, INC. | Investor Relations Contact | - |
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - |
Precedenti posizioni note di Lindsey Trickett
| Società | Posizione | Fine |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | - |
Formazione di Lindsey Trickett
| University of Kentucky | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Aziende private | 1 |
|---|---|
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Lindsey Trickett
